Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovic Halby

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Molecular Pharmacology|February 27, 2008
Targeting MDR1 gene: synthesis and cellular study of modified daunomycin-triplex-forming oligonucleotide conjugates able to inhibit gene expression in resistant cell linesVérène Stierlé, Maria Duca, Ludovic Halby, et al.
Bioconjugate Chemistry|July 21, 2005
Triple helix-forming oligonucleotides conjugated to new inhibitors of topoisomerase II: synthesis and binding propertiesMaria Duca, Kahina Oussedik, Alexandre Ceccaldi, et al.
Chemistry & Biodiversity|December 29, 2006
Sequence-specific conjugates of oligo(2'-O-methylribonucleotides) and hairpin oligocarboxamide minor-groove binders: design, synthesis, and binding studies with double-stranded DNADarya S Novopashina, Alexandre N Sinyakov, Vladimir A Ryabinin, et al.
Nucleic Acids Research|April 7, 2006
Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotidesMaria Duca, Dominique Guianvarc'h, Kahina Oussedik, et al.
Biochimie|September 13, 2012
DNA methylation inhibitors in cancer: recent and future approachesChristina Gros, Jacques Fahy, Ludovic Halby, et al.
RSC Medicinal Chemistry|March 10, 2025
Design, synthesis and evaluation of pyrimidinobenzylamide and pyrimidinothiophenamide derivatives as inhibitors of DOT1L and related epigenetic targets DNMT3a, PRMT4 and other HMTsOscar Omar Castillo-Aguilera, Patrick Depreux, Ludovic Halby, et al.
ACS Infectious Diseases|May 22, 2023
<i>Plasmodium falciparum</i> Eukaryotic Translation Initiation Factor 3 is Stabilized by Quinazoline-Quinoline Bisubstrate InhibitorsIrina Dobrescu, Elie Hammam, Jerzy M Dziekan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 25, 2010
Sequence-specific targeting of IGF-I and IGF-IR genes by camptothecinsKahina Oussedik, Jean-Christophe François, Ludovic Halby, et al.
Future Medicinal Chemistry|March 25, 2022
Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studiesCorentin Bon, Magdalena Barbachowska, Nemanja Djokovic, et al.
Nucleic Acids Research|July 11, 2003
Spatial organization of topoisomerase I-mediated DNA cleavage induced by camptothecin-oligonucleotide conjugatesPaola B Arimondo, Stéphane Angenault, Ludovic Halby, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Molecular Pharmacology|February 27, 2008
Targeting MDR1 gene: synthesis and cellular study of modified daunomycin-triplex-forming oligonucleotide conjugates able to inhibit gene expression in resistant cell linesVérène Stierlé, Maria Duca, Ludovic Halby, et al.
Bioconjugate Chemistry|July 21, 2005
Triple helix-forming oligonucleotides conjugated to new inhibitors of topoisomerase II: synthesis and binding propertiesMaria Duca, Kahina Oussedik, Alexandre Ceccaldi, et al.
Chemistry & Biodiversity|December 29, 2006
Sequence-specific conjugates of oligo(2'-O-methylribonucleotides) and hairpin oligocarboxamide minor-groove binders: design, synthesis, and binding studies with double-stranded DNADarya S Novopashina, Alexandre N Sinyakov, Vladimir A Ryabinin, et al.
Nucleic Acids Research|April 7, 2006
Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotidesMaria Duca, Dominique Guianvarc'h, Kahina Oussedik, et al.
Biochimie|September 13, 2012
DNA methylation inhibitors in cancer: recent and future approachesChristina Gros, Jacques Fahy, Ludovic Halby, et al.
RSC Medicinal Chemistry|March 10, 2025
Design, synthesis and evaluation of pyrimidinobenzylamide and pyrimidinothiophenamide derivatives as inhibitors of DOT1L and related epigenetic targets DNMT3a, PRMT4 and other HMTsOscar Omar Castillo-Aguilera, Patrick Depreux, Ludovic Halby, et al.
ACS Infectious Diseases|May 22, 2023
<i>Plasmodium falciparum</i> Eukaryotic Translation Initiation Factor 3 is Stabilized by Quinazoline-Quinoline Bisubstrate InhibitorsIrina Dobrescu, Elie Hammam, Jerzy M Dziekan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 25, 2010
Sequence-specific targeting of IGF-I and IGF-IR genes by camptothecinsKahina Oussedik, Jean-Christophe François, Ludovic Halby, et al.
Future Medicinal Chemistry|March 25, 2022
Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studiesCorentin Bon, Magdalena Barbachowska, Nemanja Djokovic, et al.
Nucleic Acids Research|July 11, 2003
Spatial organization of topoisomerase I-mediated DNA cleavage induced by camptothecin-oligonucleotide conjugatesPaola B Arimondo, Stéphane Angenault, Ludovic Halby, et al.
Pageof 4